Sleep Duration Affects Risk for Ulcerative Colitis: A Prospective Cohort Study

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 11, 2014, Pages 1879-1886

  Ananthakrishnan, Ashwin N ^a   Khalili, Hamed ^a   Konijeti, Gauree G ^a   Higuchi, Leslie M ^b   de Silva, Punyanganie ^c   Fuchs, Charles S ^b,c,d   Richter, James M ^a   Schernhammer, Eva S ^c,e   Chan, Andrew T ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Circadian Clock; Epidemiology; Inflammation; Population; Risk Factor

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CROHN DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SHIFT WORKER; SLEEP DEPRIVATION; SLEEP TIME; SMOKING; ULCERATIVE COLITIS; COLITIS, ULCERATIVE; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDY; QUESTIONNAIRE; SLEEP; TIME FACTOR;

ADULT; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SLEEP; SURVEYS AND QUESTIONNAIRES; TIME FACTORS;

EID: 84908240815     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.04.021     Document Type: Article

References (67)

1. Abraham C., Cho J.H. Inflammatory bowel disease. NEngl J Med 2009, 361:2066-2078.
2. Khor B., Gardet A., Xavier R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474:307-317.
3. Jostins L., Ripke S., Weersma R.K., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
4. Cosnes J. Smoking, physical activity, nutrition and lifestyle: environmental factors and their impact on IBD. Dig Dis 2010, 28:411-417.
5. Cosnes J., Carbonnel F., Beaugerie L., et al. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996, 110:424-431.
6. Lakatos P.L., Szamosi T., Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly?. World J Gastroenterol 2007, 13:6134-6139.
7. Danese S., Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol 2006, 12:4807-4812.
8. Higuchi L.M., Khalili H., Chan A.T., et al. Aprospective study of cigarette smoking and the risk of inflammatory bowel disease in women. Am J Gastroenterol 2012, 107:1399-1406.
9. Ananthakrishnan A.N., Higuchi L.M., Huang E.S., et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med 2012, 156:350-359.
10. Ananthakrishnan A.N., Khalili H., Higuchi L.M., et al. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012, 142:482-489.
11. Ananthakrishnan A.N., Khalili H., Konijeti G.G., et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014, 63:776-784.
12. Ananthakrishnan A.N., Khalili H., Konijeti G.G., et al. Aprospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013, 145:970-977.
13. Ananthakrishnan A.N., Khalili H., Pan A., et al. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol 2013, 11:57-62.
14. Khalili H., Ananthakrishnan A.N., Konijeti G.G., et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ 2013, 347:f6633.
15. Khalili H., Higuchi L.M., Ananthakrishnan A.N., et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology 2012, 143:1199-1206.
16. Khalili H., Higuchi L.M., Ananthakrishnan A.N., et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut 2013, 62:1153-1159.
17. Lakatos P.L. Environmental factors affecting inflammatory bowel disease: have we made progress?. Dig Dis 2009, 27:215-225.
18. Ayas N.T., White D.P., Manson J.E., et al. Aprospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003, 163:205-209.
19. Baglioni C., Battagliese G., Feige B., et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. JAffect Disord 2011, 135:10-19.
20. Banks S., Dinges D.F. Behavioral and physiological consequences of sleep restriction. JClin Sleep Med 2007, 3:519-528.
21. Buman M.P., Winkler E.A., Kurka J.M., et al. Reallocating time to sleep, sedentary behaviors, or active behaviors: associations with cardiovascular disease risk biomarkers, NHANES 2005-2006. Am J Epidemiol 2014, 179:323-334.
22. Gangwisch J.E., Heymsfield S.B., Boden-Albala B., et al. Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep 2008, 31:1087-1096.
23. Hall M.H., Okun M.L., Sowers M., et al. Sleep is associated with the metabolic syndrome in a multi-ethnic cohort of midlife women: the SWAN Sleep Study. Sleep 2012, 35:783-790.
24. Hoevenaar-Blom M.P., Spijkerman A.M., Kromhout D., et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: the MORGEN study. Sleep 2011, 34:1487-1492.
25. Hoevenaar-Blom M.P., Spijkerman A.M., Kromhout D., et al. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. Eur J Prev Cardiol 2013 Jul 3, Epub ahead of print.
26. Jiao L., Duan Z., Sangi-Haghpeykar H., et al. Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer 2013, 108:213-221.
27. Lu Y., Tian N., Yin J., et al. Association between sleep duration and cancer risk: a meta-analysis of prospective cohort studies. PLoS One 2013, 8:e74723.
28. Magee C.A., Kritharides L., Attia J., et al. Short and long sleep duration are associated with prevalent cardiovascular disease in Australian adults. JSleep Res 2012, 21:441-447.
29. Westerlund A., Bellocco R., Sundstrom J., et al. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol 2013, 28:463-473.
30. Zhang X., Giovannucci E.L., Wu K., et al. Associations of self-reported sleep duration and snoring with colorectal cancer risk in men and women. Sleep 2013, 36:681-688.
31. Fragiadaki K., Tektonidou M.G., Konsta M., et al. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. JRheumatol 2012, 39:60-62.
32. Lange T., Dimitrov S., Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci 2010, 1193:48-59.
33. Rohleder N., Aringer M., Boentert M. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 2012, 1261:88-96.
34. Simpson N., Dinges D.F. Sleep and inflammation. Nutr Rev 2007, 65:S244-S252.
35. Tang Y., Preuss F., Turek F.W., et al. Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med 2009, 10:597-603.
36. Vgontzas A.N., Zoumakis E., Bixler E.O., et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. JClin Endocrinol Metab 2004, 89:2119-2126.
37. Ranjbaran Z., Keefer L., Stepanski E., et al. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res 2007, 56:51-57.
38. Shoham S., Davenne D., Cady A.B., et al. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 1987, 253:R142-R149.
39. Ruperto N., Lovell D.J., Li T., et al. Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2010, 62:1542-1551.
40. Ali T., Madhoun M.F., Orr W.C., et al. Assessment of the relationship between quality of sleep and disease activity in inflammatory bowel disease patients. Inflamm Bowel Dis 2013, 19:2440-2443.
41. Ananthakrishnan A.N., Long M.D., Martin C.F., et al. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol 2013, 11:965-971.
42. Ranjbaran Z., Keefer L., Farhadi A., et al. Impact of sleep disturbances in inflammatory bowel disease. JGastroenterol Hepatol 2007, 22:1748-1753.
43. Hublin C., Partinen M., Koskenvuo K., et al. Shift-work and cardiovascular disease: a population-based 22-year follow-up study. Eur J Epidemiol 2010, 25:315-323.
44. Yong M., Nasterlack M., Messerer P., et al. Aretrospective cohort study of shift work and risk of cancer-specific mortality in German male chemical workers. Int Arch Occup Environ Health 2014, 87:175-183.
45. Kawachi I., Colditz G.A., Stampfer M.J., et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995, 92:3178-3182.
46. Pan A., Schernhammer E.S., Sun Q., et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med 2011, 8:e1001141.
47. Schernhammer E.S., Kroenke C.H., Laden F., et al. Night work and risk of breast cancer. Epidemiology 2006, 17:108-111.
48. Sookoian S., Gemma C., Fernandez Gianotti T., et al. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. JIntern Med 2007, 261:285-292.
49. Yu X., Rollins D., Ruhn K.A., et al. TH17 cell differentiation isregulated by the circadian clock. Science 2013, 342:727-730.
50. Patel S.R., Ayas N.T., Malhotra M.R., et al. Aprospective study of sleep duration and mortality risk in women. Sleep 2004, 27:440-444.
51. Regestein Q.R., Friebely J., Shifren J.L., et al. Self-reported sleep in postmenopausal women. Menopause 2004, 11:198-207.
52. de Souza L., Benedito-Silva A.A., Pires M.L., et al. Further validation of actigraphy for sleep studies. Sleep 2003, 26:81-85.
53. Lauderdale D.S., Knutson K.L., Yan L.L., et al. Self-reported and measured sleep duration: how similar are they?. Epidemiology 2008, 19:838-845.
54. Loftus E.V., Sandborn W.J. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002, 31:1-20.
55. Baumgart D.C., Sandborn W.J. Crohn's disease. Lancet 2012, 380:1590-1605.
56. Ordas I., Eckmann L., Talamini M., et al. Ulcerative colitis. Lancet 2012, 380:1606-1619.
57. Schernhammer E.S., Feskanich D., Liang G., et al. Rotating night-shift work and lung cancer risk among female nurses in the United States. Am J Epidemiol 2013, 178:1434-1441.
58. Swanson G.R., Burgess H.J., Keshavarzian A. Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare?. Expert Rev Clin Immunol 2011, 7:29-36.
59. Axelsson J., Rehman J.U., Akerstedt T., et al. Effects of sustained sleep restriction on mitogen-stimulated cytokines, chemokines and T helper 1/T helper 2 balance in humans. PLoS One 2013, 8:e82291.
60. Abedelmalek S., Souissi N., Chtourou H., et al. Effects of partial sleep deprivation on proinflammatory cytokines, growth hormone, and steroid hormone concentrations during repeated brief sprint interval exercise. Chronobiol Int 2013, 30:502-509.
61. Cappuccio F.P., D'Elia L., Strazzullo P., et al. Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010, 33:585-592.
62. Patel S.R., Zhu X., Storfer-Isser A., et al. Sleep duration and biomarkers of inflammation. Sleep 2009, 32:200-204.
63. Keefer L., Stepanski E.J., Ranjbaran Z., et al. An initial report of sleep disturbance in inactive inflammatory bowel disease. JClin Sleep Med 2006, 2:409-416.
64. Nojkov B., Rubenstein J.H., Chey W.D., et al. The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol 2010, 105:842-847.
65. Wells M.M., Roth L., Chande N. Sleep disruption secondary to overnight call shifts is associated with irritable bowel syndrome in residents: a cross-sectional study. Am J Gastroenterol 2012, 107:1151-1156.
66. Khalili H., Huang E.S., Ananthakrishnan A.N., et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut 2012, 61:1686-1692.
67. Amre D.K., D'Souza S., Morgan K., et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007, 102:2016-2025.